CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 46 filers reported holding CATALYST BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,512 | +3.2% | 31,303 | +80.1% | 0.00% | – |
| Q4 2021 | $16,000 | -72.4% | 17,379 | +50.7% | 0.00% | – |
| Q1 2021 | $58,000 | -63.3% | 11,529 | -68.7% | 0.00% | – |
| Q3 2020 | $158,000 | +53.4% | 36,780 | +109.2% | 0.00% | – |
| Q2 2020 | $103,000 | -3.7% | 17,583 | +21.0% | 0.00% | – |
| Q2 2019 | $107,000 | – | 14,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |